Impact of regular attendance by infectious disease specialists on the management of hospitalised adults with community-acquired febrile syndromes

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
A BorerF Schlaeffer

Abstract

The impact of attendance by infectious disease specialists (IDS) on hospitalised adults with community-acquired infection was assessed by studying 402 consecutive febrile adults who were admitted randomly to either of two internal medicine wards over a 4-month period and given intravenous antibiotics. In ward 1, patients were attended by IDS, whereas those in ward 2 were attended by physicians from other specialties. In total, 160 patients were treated in ward 1 and 242 in ward 2 (median age 66 years; 49% male). The case-mix was comparable. Only 39% of ward 2 patients underwent minimal fever diagnostic tests compared to 82% in ward 1 (p < 0.001). Ward 1 and 2 patients received 188 and 315 antibiotic courses, respectively, of which 32% and 20% required approval from IDS (p 0.003). Patients in ward 1 were more likely to receive ceftriaxone (7.5% vs. 2%; p 0.002), erythromycin (7% vs. 1.5%; p 0.002) and cefuroxime (48% vs. 26%; p < 0.0001), but were less likely to receive amoxycillin-clavulanate (8% vs. 28%; p < 0.0001). The mean durations of therapy were 3.6 and 3.2 days (not significant), and therapy was deemed to be completely appropriate in 55.5% and 43% of cases, respectively (p 0.012). The crude mortality rates were 6.3% and...Continue Reading

References

Oct 1, 1996·QJM : Monthly Journal of the Association of Physicians·D NathwaniD Parratt
Nov 1, 1996·The Journal of Antimicrobial Chemotherapy·I M Gould, B Jappy
Mar 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D C ClassenR P Wenzel
Mar 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J F John, N O Fishman
Jun 1, 1997·Infectious Disease Clinics of North America·J E McGowan, F C Tenover
Oct 14, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·V G FowlerG R Corey
Aug 5, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B BylJ P Thys
Jun 6, 2000·The Journal of Antimicrobial Chemotherapy·I M Gould, B Jappy
Sep 1, 2000·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·U FluckigerA F Widmer

❮ Previous
Next ❯

Citations

Dec 31, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·G PongasDimitrios P Kontoyiannis
Jun 6, 2013·Current Opinion in Oncology·Bruno P Granwehr, Dimitrios P Kontoyiannis
Sep 28, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Steven SchmittEric Hammelman
Feb 1, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C L BeckettB Huttner
Mar 10, 2007·International Journal of Antimicrobial Agents·Silvano Esposito, Sebastiano Leone
Jul 22, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C PulciniS Harbarth
Mar 1, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ichiro Kawamura, Hanako Kurai
Mar 25, 2015·Journal of Chemotherapy·Silvano EspositoMario Venditti
Sep 25, 2016·Soins. Gérontologie·Aurélien DinhLaurent Teillet
Aug 19, 2005·Expert Review of Anti-infective Therapy·Silvano EspositoSilvana Noviello
Apr 20, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Javeed Siddiqui
Sep 25, 2017·The Journal of Infectious Diseases·Daniel P McQuillen, Ann T MacIntyre
Dec 29, 2020·Clinical Case Reports·Abhimanyu AggarwalDurane Walker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2021 Meta ULC. All rights reserved